{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,2]],"date-time":"2025-11-02T19:58:11Z","timestamp":1762113491915,"version":"3.37.3"},"reference-count":13,"publisher":"Oxford University Press (OUP)","license":[{"start":{"date-parts":[[2015,9,1]],"date-time":"2015-09-01T00:00:00Z","timestamp":1441065600000},"content-version":"tdm","delay-in-days":274,"URL":"http:\/\/doi.wiley.com\/10.1002\/tdm_license_1.1"}],"funder":[{"DOI":"10.13039\/501100004243","name":"Prinses Beatrix spierfonds","doi-asserted-by":"crossref","award":["W.OR11-27"],"award-info":[{"award-number":["W.OR11-27"]}],"id":[{"id":"10.13039\/501100004243","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Clin Exp Immunol"],"published-print":{"date-parts":[[2014,12]]},"DOI":"10.1111\/cei.12530","type":"journal-article","created":{"date-parts":[[2014,12,29]],"date-time":"2014-12-29T12:43:26Z","timestamp":1419857006000},"page":"105-107","source":"Crossref","is-referenced-by-count":6,"special_numbering":"supplement S1","title":["Immunoglobulin G Fc N-glycosylation in Guillain-Barr\u00e9 syndrome treated with intravenous immunoglobulin"],"prefix":"10.1093","volume":"178","author":[{"given":"W.-J. R.","family":"Fokkink","sequence":"first","affiliation":[{"name":"Department of Immunology; Erasmus MC; University Medical Center Rotterdam; Rotterdam the Netherlands"},{"name":"Department of Neurology; Erasmus MC; University Medical Center Rotterdam; Rotterdam the Netherlands"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M. H. C.","family":"Selman","sequence":"additional","affiliation":[{"name":"Center for Proteomics and Metabolomics; Leiden University Medical Center; Leiden the Netherlands"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M.","family":"Wuhrer","sequence":"additional","affiliation":[{"name":"Center for Proteomics and Metabolomics; Leiden University Medical Center; Leiden the Netherlands"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"B. C.","family":"Jacobs","sequence":"additional","affiliation":[{"name":"Department of Immunology; Erasmus MC; University Medical Center Rotterdam; Rotterdam the Netherlands"},{"name":"Department of Neurology; Erasmus MC; University Medical Center Rotterdam; Rotterdam the Netherlands"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"286","published-online":{"date-parts":[[2014,12,29]]},"reference":[{"key":"10.1111\/cei.12530-BIB0001|cei12530-cit-0001","doi-asserted-by":"crossref","first-page":"939","DOI":"10.1016\/S1474-4422(08)70215-1","article-title":"Clinical features, pathogenesis, and treatment of Guillain-Barr\u00e9 syndrome","volume":"7","author":"Doorn","year":"2008","journal-title":"Lancet Neurol"},{"key":"10.1111\/cei.12530-BIB0002|cei12530-cit-0002","article-title":"Intravenous immunoglobulin for Guillain-Barr\u00e9 syndrome","volume":"7","author":"Hughes","year":"2012","journal-title":"Cochrane Database Syst Rev"},{"key":"10.1111\/cei.12530-BIB0003|cei12530-cit-0003","doi-asserted-by":"crossref","first-page":"597","DOI":"10.1002\/ana.21737","article-title":"Pharmacokinetics of intravenous immunoglobulin and outcome in Guillain-Barr\u00e9 syndrome","volume":"66","author":"Kuitwaard","year":"2009","journal-title":"Ann Neurol"},{"key":"10.1111\/cei.12530-BIB0004|cei12530-cit-0004","doi-asserted-by":"crossref","first-page":"5636","DOI":"10.4049\/jimmunol.1301536","article-title":"Sialylation of Campylobacter jejuni endotoxin promotes dendritic cell-mediated B cell responses through CD14-dependent production of IFN-beta and TNF-alpha","volume":"191","author":"Huizinga","year":"2013","journal-title":"J Immunol"},{"key":"10.1111\/cei.12530-BIB0005|cei12530-cit-0005","doi-asserted-by":"crossref","first-page":"670","DOI":"10.1126\/science.1129594","article-title":"Anti-inflammatory activity of immunoglobulin G resulting from Fc sialylation","volume":"313","author":"Kaneko","year":"2006","journal-title":"Science"},{"key":"10.1111\/cei.12530-BIB0006|cei12530-cit-0006","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1126\/science.1154315","article-title":"Recapitulation of IVIG anti-inflammatory activity with a recombinant IgG Fc","volume":"320","author":"Anthony","year":"2008","journal-title":"Science"},{"key":"10.1111\/cei.12530-BIB0007|cei12530-cit-0007","doi-asserted-by":"crossref","first-page":"176","DOI":"10.1038\/nri3401","article-title":"Intravenous immunoglobulin therapy: how does IgG modulate the immune system?","volume":"13","author":"Schwab","year":"2013","journal-title":"Nat Rev Immunol"},{"key":"10.1111\/cei.12530-BIB0008|cei12530-cit-0008","doi-asserted-by":"crossref","first-page":"1722","DOI":"10.1021\/pr401213z","article-title":"IgG Fc N-glycosylation in Guillain-Barr\u00e9 syndrome treated with immunoglobulins","volume":"13","author":"Fokkink","year":"2014","journal-title":"J Proteome Res"},{"key":"10.1111\/cei.12530-BIB0009|cei12530-cit-0009","doi-asserted-by":"crossref","first-page":"17","DOI":"10.3233\/CBM-130373","article-title":"Glycosylation as a marker for inflammatory arthritis","volume":"14","author":"Albrecht","year":"2014","journal-title":"Cancer Biomark"},{"key":"10.1111\/cei.12530-BIB0010|cei12530-cit-0010","doi-asserted-by":"crossref","first-page":"1123","DOI":"10.1056\/NEJM199204233261705","article-title":"A randomized trial comparing intravenous immune globulin and plasma exchange in Guillain-Barr\u00e9 syndrome. Dutch Guillain-Barr\u00e9 Study Group","volume":"326","author":"Meche","year":"1992","journal-title":"N Engl J Med"},{"key":"10.1111\/cei.12530-BIB0011|cei12530-cit-0011","doi-asserted-by":"crossref","first-page":"192","DOI":"10.1016\/S0140-6736(03)15324-X","article-title":"Effect of methylprednisolone when added to standard treatment with intravenous immunoglobulin for Guillain-Barr\u00e9 syndrome: randomised trial","volume":"363","author":"Koningsveld","year":"2004","journal-title":"Lancet"},{"key":"10.1111\/cei.12530-BIB0012|cei12530-cit-0012","doi-asserted-by":"crossref","first-page":"471","DOI":"10.1016\/j.coi.2008.06.007","article-title":"Terminal sugars of Fc glycans influence antibody effector functions of IgGs","volume":"20","author":"Raju","year":"2008","journal-title":"Curr Opin Immunol"},{"key":"10.1111\/cei.12530-BIB0013|cei12530-cit-0013","doi-asserted-by":"crossref","first-page":"4522","DOI":"10.1021\/pr400589m","article-title":"Association between galactosylation of immunoglobulin G and improvement of rheumatoid arthritis during pregnancy is independent of sialylation","volume":"12","author":"Bondt","year":"2013","journal-title":"J Proteome Res"}],"container-title":["Clinical & Experimental Immunology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Fcei.12530","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/onlinelibrary.wiley.com\/wol1\/doi\/10.1111\/cei.12530\/fullpdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,1,1]],"date-time":"2022-01-01T16:27:25Z","timestamp":1641054445000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1111\/cei.12530"}},"subtitle":["Guillain-Barr\u00e9 syndrome treated with IVIg"],"short-title":[],"issued":{"date-parts":[[2014,12]]},"references-count":13,"URL":"https:\/\/doi.org\/10.1111\/cei.12530","archive":["Portico"],"relation":{},"ISSN":["0009-9104"],"issn-type":[{"type":"print","value":"0009-9104"}],"subject":[],"published":{"date-parts":[[2014,12]]}}}